Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 8:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 2,650 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pilot Group Clear all

Conditions: Heart Failure; With Decompensation
Interventions: Bumetanide, Furosemide; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Chronic Kidney Disease, Endstage Renal Disease
Interventions: Arteriovenous Fistula (AVF), Arteriovenous Graft (AVG); Procedure
Lead sponsor: Columbia University; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Eating Disorders (Excluding Anorexia Nervosa), Binge-Eating Disorder
Interventions: Building Healthy Eating and Self-Esteem Together for University Students, Present-Centered Therapy; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years to 65 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Lawrence, Kansas

Conditions: Type 1 Diabetes, Type 2 Diabetes
Interventions: I-PORT, standard injections; Device · Other
Lead sponsor: Texas Diabetes & Endocrinology, P.A.; Other
Eligibility: 18 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Heart Failure
Interventions: Teaching for Interactive Patient Self-Management (TIPS) for Heart Failure (HF; Behavioral
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 55 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 2
States / cities: Charleston, South Carolina • Columbia, South Carolina

Conditions: Malignant Breast Neoplasm, Malignant Digestive System Neoplasm, Peripheral Neuropathy
Interventions: Massage Therapy, Quality-of-Life Assessment, Questionnaire Administration; Procedure · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Illnesses
Interventions: Comprehensive Care with Inpatient consultation, Usual Inpatient Care; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: Up to 18 Years
Enrollment: 342 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Depressive Symptoms
Interventions: Group-based therapy; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 18 Years to 28 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Eugene, Oregon

Conditions: Frail Elderly, Aortic Valve Stenosis
Interventions: Supervised TAVR Exercise Program; Behavioral
Lead sponsor: OSF Healthcare System; Other
Eligibility: 50 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Peoria, Illinois

Conditions: Physical Activity
Interventions: 5 A communication intervention; Other
Lead sponsor: University of Rochester; Other
Eligibility: 30 Years to 50 Years
Enrollment: 325 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Hypertension, End Stage Renal Disease
Interventions: Vasopressin - Very Low Dose, Vasopressin - Low Dose, Placebo Comparator; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiac Disease
Interventions: 1.8% lidocaine plus 0.76% sodium bicarbonate, Air; Drug · Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Stroke, Balance; Distorted
Interventions: Body weight support system control group, Body weight support system with balance perturbations; Device
Lead sponsor: Gaylord Hospital, Inc; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Wallingford, Connecticut

Conditions: Blunt Cerebrovascular Injury
Interventions: Aspirin 325Mg Tab, Aspirin 81Mg Tab; Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years and older
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Post-operative Pneumonia, Lung Cancer, Esophageal Cancer
Interventions: 0.12% chlorhexidine solution; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Systemic Lupus Erythematosus
Interventions: Fish Oil, Olive Oil; Dietary Supplement
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 64 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Prediabetes
Interventions: National Diabetes Prevention Program (DPP), Sleep Health Digital Application, Time-Restricted Eating (TRE); Behavioral
Lead sponsor: University of Delaware; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Gingivitis
Interventions: Stannous fluoride; Drug
Lead sponsor: Procter and Gamble; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Pregnancy Related, Infant Development, Adherence, Treatment, Activity, Motor
Interventions: Supervised Exercise, Home Exercise; Behavioral
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: COVID-19
Interventions: Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo; Drug · Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Gold Nanocrystals; Drug
Lead sponsor: Clene Nanomedicine; Industry
Eligibility: 35 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Alcohol Use Disorder, Hazardous Alcohol Use
Interventions: LDART, Psychoeducational control; Device · Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Cervical Cancer, Uterine Endometrial Cancer, Ovarian Cancer
Interventions: Laparotomy, intravenous narcotics, standard anesthesia, regional anesthesia, Non-steroidal anti-inflammatory drugs; Procedure · Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 19 Years and older
Enrollment: 103 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Vaginitis
Interventions: Terazol or oral fluconazole for candidal vaginitis, Metronidazole or Clindamycin for Bacterial Vaginosis, Flagyl for definitively diagnosed vaginal trichomoniasis, Empiric Management; Drug · Other
Lead sponsor: Agency for Healthcare Research and Quality (AHRQ); Federal
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 46 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: The Bronx, New York

Search by objective public record fields.

A Study of Ultra High Dose Diuretics to Treat Heart Failure

Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis

Building Healthy Eating and Self-Esteem Together for University Students

Safety Study of Using Symlin Alongside Insulin in a Multiple Injection Port

Telehealth Self Management for CHF

Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies

Inpatient Consultation for High-Risk Chronically Ill Children Receiving Care in an Enhanced Medical Home

Pilot Study Comparing Two Versions of Group Cognitive-behavioral Indicated Prevention Programs

A STEP for Patients Prior to Undergoing TAVR: A Pilot Study

Communication Intervention Physical Activity

Study of the Effect of Intradialytic Vasopressin on Chronic Hypertension in Patients With End Stage Renal Disease

Lidocaine as an Endotracheal Tube (ETT) Cuff Media

Explorations of the Benefits of the ZeroG TRiP System to Improve Balance in Patients Following Stroke

Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA).

Prevention of Post-operative Pneumonia (POPP)

Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus

Nested Pilot Study Comparing Two Treatments to Reduce Type 2 Diabetes Risk in At-Risk Delawareans

Stannous Fluoride and Gingivitis

The SPROUT (Pilot) Project

A Pilot Clinical Evaluation of Astepro® Nasal Spray for Management of Early SARS-CoV-2 Infection

31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)

LDART for Alcohol Use Disorder

Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study

Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network